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Abstract—In this paper an amperometric electrochemical
detection method is demonstrated and implemented using
exclusively Printed Circuit Board (PCB)-based technologies.
A portable, reconfigurable, multichannel amperometric data-
acquisition board has been designed and fabricated, dedicated
to the measurement of current-input signals delivered by the
PCB-based biosensor. The electronic read-out circuit is able to
provide constant biasing voltages to the amperometric sensor,
measure in real-time the sensor’s output currents, digitise them
using high-accuracy Analog-to-Digital Converters (ADCs) and
send the binary data to the user either through a USB2.0 interface
or via an on-board TFT touch-screen. In order to validate
the robustness and accuracy of the combined system, proof-of-
concept amperometric experiments have taken place using our
custom-made PCB-based system and standard electrochemical
substrates. The results obtained have been cross-validated by
means of standard colorimetric analysis and their differences
have been highlighted and analysed.
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I. INTRODUCTION
The modern era has seen extraordinary advances in medical
science and analytical technologies and our understanding of
the precise biomolecular epidemiology that underlies patho-
logical processes has improved considerably [1]. Diagnostic
and prognostic biomarkers for many common diseases are
being revealed in much greater detail, driven by significant
advances in detection technology and sensitivity. As a result,
diagnostic systems are required to identify biomarkers at
very low concentrations, e.g. pg/mL. Furthermore, increased
biomolecular analysis as part of the diagnostic process requires
a higher level of diagnostic efficiency and portability. For these
reasons traditional “gold standard” techniques such as the
Enzyme Linked Immuno-Sorbent Assay (ELISA) are evolving
towards full automation and more efficient methodologies
of signal resolution. Amperometry has been shown to be
an effective conduit for ELISA signal detection due to the
electrochemically active nature of many existing colorimetric
and fluorimetric reporter compounds [2], [3].
We present the natural progression of amperometric re-
search technology into a lightweight, versatile, low-cost assay
system manufactured fully on PCBs. Assay technology has
been engineered to occur directly at the PCB surface and
amperometric detection of a common colorimetric product is
demonstrated at higher sensitivity than is allowed by colori-
metric protocols. Thus, the system can be used to significantly
increase the sensitivity of most industry standard diagnostic
ELISA kits and improve their portability, due to the exclu-
sion of bulky high-sensitivity spectrometric apparatus. With
this technology we can quantify biochemical reporters using
standard electronic techniques, both in analog and in digital
domain, without the need to convert the optical signal into a
current or voltage.
In Point-of-Care (POC) applications, a handheld, electronic
ELISA (“eELISA”) has long been viewed as the next step
in future diagnostic technology. In order to provide accurate
electrical colorimetrically analogous results from an “eELISA”,
an electronic read-out circuit is required. In this paper, we
propose a complete, proof-of-concept system, including a
multi-channel data acquisition board and a passive PCB-based
sensor, where the molecular “eELISA” is taking place. The
preliminary results obtained with the described technology,
allow us to proceed with an embedded system, where the read-
out electronics and biosensors would communicate in a fully-
integrated user-friendly manner within an architecture that per-
mits multiplexed detection across a range of interchangeable
assay chips [4], [5].
We discuss initially the concept of the “eELISA” and
present the data-acquisition board in detail. Subsequently, we
show preliminary amperometric analyses with comparison to
existing colorimetric systems. Finally, we offer some conclu-
sions and future prospects for the presented technology.
II. THE “eELISA” DETECTION APPROACH
The amperometric detection method utilised in this analysis
is often described as second generation amperometry [6].
Unlike other amperometric approaches this system does not
rely on reactions occurring at the electrode but measures
charge carrier concentration directly in the form of distinct
current levels. In order to integrate amperometric detection into
standard immunodiagnostic assay systems it is necessary only
that the reporter component deliver a measurable change in
charge carriage capable species.
A reporter system commonly employed in colorimet-
ric ELISAs is the enzymatic conversion of 3, 3′, 5, 5′-
Tetramethylbenzidine (TMB) to the corresponding diimine by
the horseradish peroxidase (HRP) enzyme (TMB is colour-
less, while the diimine product is bright blue) [7]. Hydrogen
peroxide (H2O2) is consumed as a co-factor in this process,
providing free hydroxyl ions to the solution. Both the TMB
diimine product and hydroxyl ions are charge carriage capable
and therefore electrochemically detectable, thus, theoretically,
Fig. 1. The proposed “eELISA” system. In (A) and (B) the top and bottom
side of the boinstrumentation board can be seen, respectively. On the top layer
the ADC for the first eight channels is located, while on the bottom layer the
second ADC for the remaining eight channels can be seen. In (C) the PCB-
based sensor is shown with its 285 sensor plates, while in (D) a schematic
representation of a cross-section of the sensor’s architecture is provided.
allowing any standard TMB assay to be assessed amperometri-
cally. Our intention includes the improved sensitivity of exist-
ing immunodiagnostic assay systems through the replacement
of standard colorimetry with amperometric detection.
A. The PCB-Based Amperometric Sensor
The fabricated PCB-based sensing system can be seen in
Figure 1(C). The sensor surface is comprised of three gold
electrodes on a PCB forming working, counter and reference
electrodes. Gold provides a stable amperometric sensor surface
and allows thiol linkage to single chain cysteine modified anti-
body fragment (Fab′) so that diagnostic assay chemistry can be
performed directly at the sensor. All sensor surfaces measure
2.4x1.2mm and are commercially fabricated by deposition of
a thin layer of gold over a standard thickness copper contact
pad. Wells were fabricated from PDMS and fixed to the PCB to
allow introduction of samples to the electrode surfaces under
conditions through which the current path in the electrolyte
could be controlled. A schematic representation of a cross-
section of the sensor’s architecture is shown in Figure 1(D).
B. The Multichannel Amperometric Bioinstrumentation Board
An electronic multi-channel, reconfigurable, portable bioin-
strumentation platform has been designed, fabricated and pro-
grammed for the appropriate interface with the aforementioned
PCB-based sensors. A view of the top and bottom layers
of the fabricated board can be found in Figure 1(A) and
(B), where all its distinct compartments are marked-up. A
commercially available development board which includes an
ATxmega128A1 microcontroller for the control of the various
Integrated Circuits (ICs) and a 2.8-inch TFT touch-screen has
been connected to the bottom layer of our custom-made PCB
using standard board-to-board connectors.
Two, fully-differential eight channel, 16-bit resolution
voltage-input ADCs have been employed for the digitisation
of the converted current values received from the front-end
low-noise transimpedance amplifiers (TIAs) LTC2055. All
16 TIAs include 0.1% tolerance resistors for precise and
matched current readings and appropriate value capacitors
for the filtering of high-frequency noise. The ADCs operate
with bipolar power supply (±2.5V ) and thus, are able to
detect positive and negative reaction currents. The overall
design of the board revolves around the idea of immediate
digitisation of the analog biosensor signals, process them by
means of standard DSP techniques and finally send them to
the user in digital or in analog form [8]. The system can be
powered-up via a USB-connection or by a single 5V battery,
ensuring its portability. A simplified schematic diagram of the
complete electronic platform is shown in Figure 2, including
the data retrieval timings for the Serial Peripheral Interface
(SPI) communication protocol been used for the two ADCs.
With the use of the 12-bit, single-output Digital-to-Analog
Converter (DAC) AD5321 and an appropriate circuitry, the
bioinstrumentation board can provide bipolar biasing voltages
to the sensor from -3.3V up to +3.3V with a resolution of
∼1.6mV, using the standard three-electrode potentiostat archi-
tecture (see Figure 2). The electronic system is able to read-out
simultaneously from 16-channels in a real-time manner and
dynamically change the gain of the internal Programmable
Gain Amplifiers (PGAs) of the ADCs, if the readings are
below certain threshold values. Moreover, through the on-
board DAC, the user is able to perform a Cyclic Voltammetry
(CV) calibration before every measurement, if necessary. Table
I summarises the characteristics of the fabricated board.
TABLE I. BIOINSTRUMENTATION BOARD’S CHARACTERISTICS
Input current range (dB) 90.3
Input current resolution (nA) 122
ADCs resolution (bit) 16
ADCs data rate (kSPS) 0.125 - 8
Board dimensions (mm) 83 x 93
DSP unit ATxmega128A1 - 32MHz
Total current required for
the fabricated PCB of Figure 1 (mA) ∼ 45
Power supply 5V (Battery or USB)
III. ELECTROCHEMICAL RESULTS
We require a system that shows clear definition between
measured sample currents but we also wish to minimise the
biasing voltage to reduce damage observed at the gold sensor
surface following repeated measurements. Performance was as-
sessed through standard CV under different biasing voltages to
establish effective sensor calibration. Negative bias values from
0 to -400mV with 50mV steps were investigated. Analytes
of various TMB product concentration were produced as de-
scribed below and three distinct samples corresponding to low,
medium and high colorimetric levels were measured at each
biasing voltage. CV showed -300mV to provide maximum
signal elevation and thus, optimum system sensitivity, without
showing excessive deterioration of sensor surface integrity
under extended or repeated analysis.
Subsequently, a number of experiments were conducted to
verify the performance of our system. The sensor’s drift was
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Fig. 2. A simplified schematic diagram of the fabricated bioinstrumentation board that interfaces with the PCB-based sensor.
assessed by measuring the current delivered across three TMB
product solutions at high, medium and low concentrations
(relative to the full colorimetrically detectable range). A 5mN
(PO3−4 ) phosphate-buffered saline (PBS) was included to high-
light drift occurring due to electro-adsorption of components
of the HRP-TMB reporter systems to the sensor surface.
The aforementioned -300mV constant bias was applied to the
reference electrode and current recorded over three minutes
(a x6 time period, since the proposed assay time is 30s). The
results are shown in Table II.
TABLE II. PCB-BASED SENSOR DRIFT
High [TMB] Medium [TMB] Low [TMB] PBS (5mN)
Drift (nA/s) 180 112 86 13.3
The observed linearity demonstrates quantification capable
measurement during the time window of interest and that
our chosen analysis time of 30 seconds is appropriate. Com-
parison of TMB samples (containing biological components
such as HRP) to PBS alone shows that some of the drift is
attributable to sample composition and is suggested to result
from electrochemical adsorption to the sensor surface, higher
concentrations of biological components lead to higher levels
of drift. We suggest that non-biologically related sensor drift
results from progressive sensor surface degradation.
Next we assessed TMB product detection in comparison
to the colorimetric system. Analytical samples containing
roughly titrated quantities of detectable TMB product were
achieved by preparing a 12 point Log2 dilution scheme of
HRP in deionised H2O and adding 10µL of each dilution
to 100µL of freshly prepared TMB reagent (1 TMB tablet
-Sigma T5525- dissolved in 10mL 0.014% H2O2, centrifuged
16850 RCF/1min to remove particulates and decanted to a
fresh tube). When appropriate colorimetric values had been
achieved the reaction was stopped by addition of 10µL 1M
H2SO4. Samples were then measured colorimetrically using a
Promega Glomax R© plate reader, and amperometrically using
the bioinstrumentation board described herein. Amperometric
sensor surfaces were rinsed x1 with 2M HCl and x3 with H2O
between measurements. The produced current was measured
for 30 seconds and final endpoint values collected. The re-
sulting data in Figure 3 demonstrate that the amperometric
linear detection range of TMB product concentration extends
throughout and beyond that of colorimetric detection allowing
a greater range of sample concentrations to be assessed through
a single reagent protocol. The correlation is closely linear as
required for effective biodetection.
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Fig. 3. Comparative colorimetric versus amperometric sensing results for a
Log2 dilution scheme of HRP.
Further investigation was conducted by preparing a shal-
lower HRP dilution scheme (Log1.25) to analyse amperometric
detection resolution at lower TMB product concentrations and
the results are presented in Figure 4. We demonstrate that
the linear correlation between TMB product and amperometric
response extends to concentrations that are essentially unde-
tectable by colorimetry. This discovery implies that the system
will naturally allow the higher assay sensitivity required in
modern medical biomarker analyses. In many colorimetric
ELISAs, assay sensitivity is limited by the resolution in optical
detection of the assay product. Here, we have shown that TMB
product concentrations that are undetectable by optical density
can be discriminated by amperometry thus, allowing improved
assay sensitivity without changing any molecular aspects of the
assay or protocol.
We further analysed our low concentration detection results
of Figure 4 by expressing the difference between sequential
points as a percentage increase and plotting the results in
Figure 5. A broadly linear increase is seen for the whole
amperometric dataset, while the colorimetric data indicate
that progressive absorbance in the low concentration analysis
only occurs at the highest two points. Thus, highlighting
the improved detection sensitivity provided by the described
amperometric system.
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Fig. 4. Colorimetric versus amperometric sensing results for a Log1.25
dilution scheme of HRP allowing measurement of lower TMB product
concentrations, compared to Figure 3. (The final TMB product concentration
depends on both HRP dilution and development time, thus, cross-comparison
of Figure 3 and Figure 4 is achieved by colorimetric values rather than HRP
dilution factor.)
IV. CONCLUSION
This paper presents an electrochemical detection platform,
developed using commercially available PCB technologies.
The proposed system comprises the custom-made sensor and
a multi-channel bioinstrumentation board, built entirely from
discrete “off-the-shelf ” components. The electronic board can
be powered-up by a battery or via USB connection, depending
whether a lab- or POC-based application is required. The
presented experimental results demonstrate that the behaviour
of the “eELISA” approach is similar to the standard col-
orimetric ELISA protocol and more specifically, in lower
concentrations the “eELISA” exhibits higher sensitivity than
the colorimetric method. These encouraging results allow us
to proceed to the development of a final POC system version,
which will combine a similar electronic board with a PCB-
based sensing platform, including an embedded PCB-based
microfluidic network [9].
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Fig. 5. Percentage difference within the obtained amperometric and col-
orimetric results. The “eELISA” method demonstrates a roughly linear signal
increase in response to TMB product concentration at levels producing no
consistent colorimetric readings.
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